Lista de obras - Linda Lua - Dominio Público Uruguay

A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines.

artículo científico publicado en 2011

Antibody-Binding, Antifouling Surface Coatings Based on Recombinant Expression of Zwitterionic EK Peptides

artículo científico publicado en 2018

Baculovirus-driven protein expression in insect cells: A benchmarking study.

artículo científico publicado en 2018

Bioengineering virus-like particles as vaccines

artículo científico

Biomolecular engineering of virus-like particles aided by computational chemistry methods.

artículo científico

Characterization of the Plasmodium falciparum M17 leucyl aminopeptidase. A protease involved in amino acid regulation with potential for antimalarial drug development

artículo científico publicado en 2007

Characterizing Enterovirus 71 and Coxsackievirus A16 virus-like particles production in insect cells.

artículo científico publicado en 2015

Co-administration of non-carrier nanoparticles boosts antigen immune response without requiring protein conjugation.

artículo científico publicado en 2014

Design strategies to address the effect of hydrophobic epitope on stability and in vitro assembly of modular virus-like particle

artículo científico publicado en 2016

Effect of time of harvest of budded virus on the selection of baculovirus FP mutants in cell culture.

artículo científico publicado en 2003

Energetic changes caused by antigenic module insertion in a virus-like particle revealed by experiment and molecular dynamics simulations

artículo científico publicado en 2014

Evaluation of three adjuvants with respect to both adverse effects and the efficacy of antibody production to the Bm86 protein

artículo científico publicado en 2017

Growth, viral production and metabolism of a Helicoverpa zea cell line in serum-free culture.

artículo científico publicado en 2003

High-level expression of soluble viral structural protein in Escherichia coli.

artículo científico publicado en 2008

Insert engineering and solubility screening improves recovery of virus-like particle subunits displaying hydrophobic epitopes

artículo científico publicado en 2015

Integrated molecular and bioprocess engineering for bacterially produced immunogenic modular virus-like particle vaccine displaying 18 kDa rotavirus antigen

artículo científico publicado en 2016

Intensified Downstream Processing of Monoclonal Antibodies Using Membrane Technology

scientific article published on 01 October 2020

Introduction

scientific article published on 21 October 2015

Is Pichia pastoris a realistic platform for industrial production of recombinant human interferon gamma?

artículo científico publicado en 2016

Liposome reconstitution and modulation of recombinant N-methyl-D-aspartate receptor channels by membrane stretch

artículo científico publicado en 2007

Microbial bio-production of a recombinant stimuli-responsive biosurfactant.

artículo científico publicado en 2009

Microbially synthesized modular virus-like particles and capsomeres displaying group A streptococcus hypervariable antigenic determinants.

artículo científico publicado en 2013

Modular virus-like particles for sublingual vaccination against group A streptococcus.

artículo científico publicado en 2016

Non-carrier nanoparticles adjuvant modular protein vaccine in a particle-dependent manner.

artículo científico publicado en 2015

Non-chromatographic preparation of a bacterially produced single-shot modular virus-like particle capsomere vaccine for avian influenza.

artículo científico publicado en 2015

Platform technologies for modern vaccine manufacturing.

artículo científico publicado en 2017

Possible roles for Munc18-1 domain 3a and Syntaxin1 N-peptide and C-terminal anchor in SNARE complex formation

artículo científico publicado en 2010

Preface

artículo científico publicado en 2017

Progression of continuous downstream processing of monoclonal antibodies: Current trends and challenges

scientific article published on 18 October 2018

Protective efficacy of a bacterially produced modular capsomere presenting M2e from influenza: extending the potential of broadly cross-protecting epitopes.

artículo científico publicado en 2014

Quantitative analysis of virus-like particle size and distribution by field-flow fractionation.

artículo científico publicado en 2008

Quaternary size distribution of soluble aggregates of glutathione-S-transferase-purified viral protein as determined by asymmetrical flow field flow fractionation and dynamic light scattering.

artículo científico publicado en 2008

Self-adjuvanting modular virus-like particles for mucosal vaccination against group A streptococcus (GAS).

artículo científico publicado en 2013

Sensitivity of immune response quality to influenza helix 190 antigen structure displayed on a modular virus-like particle.

artículo científico publicado en 2013

Small-Molecule Inhibitors of the SOX18 Transcription Factor.

artículo científico publicado en 2017

Structural-based designed modular capsomere comprising HA1 for low-cost poultry influenza vaccination

artículo científico publicado en 2016

Synthetic biology design to display an 18 kDa rotavirus large antigen on a modular virus-like particle.

artículo científico publicado en 2015

Synthetic biology for bioengineering virus-like particle vaccines

scientific article published on 31 December 2018

The chromatography-free release, isolation and purification of recombinant peptide for fibril self-assembly.

artículo científico publicado en 2009

The structure of the caspase recruitment domain of BinCARD reveals that all three cysteines can be oxidized

artículo científico publicado en 2013

Vaccine Technology VI: Innovative and integrated approaches in vaccine development.

artículo científico publicado en 2018

Virus assembly occurs following a pH- or Ca2+-triggered switch in the thermodynamic attraction between structural protein capsomeres.

artículo científico publicado en 2009

Virus-like particle formulation optimization by miniaturized high-throughput screening.

artículo científico publicado en 2013

Lista de obras de Linda Lua

A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines.

Antibody-Binding, Antifouling Surface Coatings Based on Recombinant Expression of Zwitterionic EK Peptides

Baculovirus-driven protein expression in insect cells: A benchmarking study.

Bioengineering virus-like particles as vaccines

Biomolecular engineering of virus-like particles aided by computational chemistry methods.

Characterization of the Plasmodium falciparum M17 leucyl aminopeptidase. A protease involved in amino acid regulation with potential for antimalarial drug development

Characterizing Enterovirus 71 and Coxsackievirus A16 virus-like particles production in insect cells.

Co-administration of non-carrier nanoparticles boosts antigen immune response without requiring protein conjugation.

Design strategies to address the effect of hydrophobic epitope on stability and in vitro assembly of modular virus-like particle

Effect of time of harvest of budded virus on the selection of baculovirus FP mutants in cell culture.

Energetic changes caused by antigenic module insertion in a virus-like particle revealed by experiment and molecular dynamics simulations

Evaluation of three adjuvants with respect to both adverse effects and the efficacy of antibody production to the Bm86 protein

Growth, viral production and metabolism of a Helicoverpa zea cell line in serum-free culture.

High-level expression of soluble viral structural protein in Escherichia coli.

Insert engineering and solubility screening improves recovery of virus-like particle subunits displaying hydrophobic epitopes

Integrated molecular and bioprocess engineering for bacterially produced immunogenic modular virus-like particle vaccine displaying 18 kDa rotavirus antigen

Intensified Downstream Processing of Monoclonal Antibodies Using Membrane Technology

Introduction

Is Pichia pastoris a realistic platform for industrial production of recombinant human interferon gamma?

Liposome reconstitution and modulation of recombinant N-methyl-D-aspartate receptor channels by membrane stretch

Microbial bio-production of a recombinant stimuli-responsive biosurfactant.

Microbially synthesized modular virus-like particles and capsomeres displaying group A streptococcus hypervariable antigenic determinants.

Modular virus-like particles for sublingual vaccination against group A streptococcus.

Non-carrier nanoparticles adjuvant modular protein vaccine in a particle-dependent manner.

Non-chromatographic preparation of a bacterially produced single-shot modular virus-like particle capsomere vaccine for avian influenza.

Platform technologies for modern vaccine manufacturing.

Possible roles for Munc18-1 domain 3a and Syntaxin1 N-peptide and C-terminal anchor in SNARE complex formation

Preface

Progression of continuous downstream processing of monoclonal antibodies: Current trends and challenges

Protective efficacy of a bacterially produced modular capsomere presenting M2e from influenza: extending the potential of broadly cross-protecting epitopes.

Quantitative analysis of virus-like particle size and distribution by field-flow fractionation.

Quaternary size distribution of soluble aggregates of glutathione-S-transferase-purified viral protein as determined by asymmetrical flow field flow fractionation and dynamic light scattering.

Self-adjuvanting modular virus-like particles for mucosal vaccination against group A streptococcus (GAS).

Sensitivity of immune response quality to influenza helix 190 antigen structure displayed on a modular virus-like particle.

Small-Molecule Inhibitors of the SOX18 Transcription Factor.

Structural-based designed modular capsomere comprising HA1 for low-cost poultry influenza vaccination

Synthetic biology design to display an 18 kDa rotavirus large antigen on a modular virus-like particle.

Synthetic biology for bioengineering virus-like particle vaccines

The chromatography-free release, isolation and purification of recombinant peptide for fibril self-assembly.

The structure of the caspase recruitment domain of BinCARD reveals that all three cysteines can be oxidized

Vaccine Technology VI: Innovative and integrated approaches in vaccine development.

Virus assembly occurs following a pH- or Ca2+-triggered switch in the thermodynamic attraction between structural protein capsomeres.

Virus-like particle formulation optimization by miniaturized high-throughput screening.